Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 436 AL 450

The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology

Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A.

Rev Neurosci. 2010;21(2):83-93. doi: 10.1515/revneuro.2010.21.2.83.

Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues

Obulesu M, Rao DM.

Int J Neurosci. 2010 Aug;120(8):531-7. doi: 10.3109/00207451003760080.

Yeast as a model for studying Alzheimer's disease

Bharadwaj P, Martins R, Macreadie I.

FEMS Yeast Res. 2010 Dec;10(8):961-9. doi: 10.1111/j.1567-1364.2010.00658.x.

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment

Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators.

Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. doi: 10.1016/j.neurobiolaging.2010.04.011.

Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans

Hua X, Hibar DP, Lee S, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1463-80. doi: 10.1016/j.neurobiolaging.2010.04.033.

[Effect of compound Polygonum multiflorum extract on Alzheimer's disease]

Chen L, Huang J, Xue L.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jun;35(6):612-5. doi: 10.3969/j.issn.1672-7347.2010.06.012.

Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease

Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, Decarli C, Farrer LA, Kurz A; MIRAGE Study Group.

Neurology. 2010 Jul 13;75(2):137-42. doi: 10.1212/WNL.0b013e3181e7ca97.

Molecular mechanisms of regeneration in Alzheimer's disease brain

Uchida Y.

Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S158-68. doi: 10.1111/j.1447-0594.2010.00607.x.

The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease

Murakami K, Masuda Y, Shirasawa T, Shimizu T, Irie K.

Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S169-79. doi: 10.1111/j.1447-0594.2010.00598.x.

Is elevated norepinephrine an etiological factor in some cases of Alzheimer's disease?

Fitzgerald PJ.

Curr Alzheimer Res. 2010 Sep;7(6):506-16. doi: 10.2174/156720510792231775.

[Animal models of Alzheimer's disease for preclinical research.]

Takahashi H.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):6-10. doi: 10.1254/fpj.136.6.

[Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.]

Fukushima T.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):11-4. doi: 10.1254/fpj.136.11.

[Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.]

Shitaka Y, Mitani Y, Nagakura A, Miyake A, Matsuoka N.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):15-20. doi: 10.1254/fpj.136.15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias